In current study, we examined the expression of Gal-9 in 140 HBV-associated HCC tumor tissues, evaluated the association between Gal-9 expression and clinicopathological features, and also evaluated its prognostic value in HBV-associated HCC. This evidence concerns the gene LGALS9 and hepatocellular carcinoma.